Loss of TBK1 Induces Epithelial-Mesenchymal Transition in the Breast Cancer Cells by ERα Downregulation

被引:29
|
作者
Yang, Kyung-Min [1 ]
Jung, YunShin [1 ]
Lee, Jeong-Mi [1 ,2 ]
Kim, WonJoo [1 ]
Cho, Jin Ki [1 ,3 ]
Jeong, Joon [4 ]
Kim, Seong-Jin [1 ,3 ]
机构
[1] CHA Univ, CHA Canc Inst, Seoul 135081, South Korea
[2] CHA Univ, Coll Pharm, Seoul 135081, South Korea
[3] CHA Univ, Dept Biomed Sci, Seoul 135081, South Korea
[4] Yonsei Univ, Coll Med, Dept Surg, Gangnam Severance Hosp, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
ESTROGEN-RECEPTOR-ALPHA; GENE-EXPRESSION; E-CADHERIN; TRANSCRIPTION; MECHANISMS; PHOSPHORYLATION; METASTASIS; RESISTANCE; SURVIVAL; THERAPY;
D O I
10.1158/0008-5472.CAN-13-0891
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Estrogen receptor alpha (ER alpha) is the pivotal regulator of proliferation and differentiation in mammary epithelia, where it serves as a crucial prognostic marker and therapeutic target in breast cancer. In this study, we show that the loss of the kinase TANK-binding kinase 1 (TBK1) induces epithelial-mesenchymal transition in ER alpha-positive breast cancer cells by downregulating ER alpha expression. TBK1 was overexpressed in ERa-positive breast cancers, where it was associated with distant metastasis-free survival in patients, whereas it was underexpressed in ER alpha-negative breast cancers. TBK1 silencing decreased expression of epithelial markers and increased expression of mesenchymal markers in ER alpha-positive breast cancer cells, enhancing tumor growth and lung metastasis in vivo in a manner associated with downregulation of ER alpha expression. Mechanistically, TBK1 silencing reduced FOXO3A binding to the ER alpha promoter by inducing the translocation of phosphorylated FOXO3A from the nucleus to the cytoplasm. Thus, our results indicate that the loss of TBK1 expression parallels the loss of ER alpha expression, in turn helping drive an aggressive breast cancer phenotype. (C) 2013 AACR.
引用
收藏
页码:6679 / 6689
页数:11
相关论文
共 50 条
  • [41] SOX4 Induces Epithelial-Mesenchymal Transition and Contributes to Breast Cancer Progression
    Zhang, Jianchao
    Liang, Qian
    Lei, Yang
    Yao, Min
    Li, Lili
    Gao, Xiaoge
    Feng, Jingxin
    Zhang, Yu
    Gao, Hongwen
    Liu, Dong-Xu
    Lu, Jun
    Huang, Baiqu
    CANCER RESEARCH, 2012, 72 (17) : 4597 - 4608
  • [42] Overexpression of angiotensin II type 1 receptor induces epithelial-mesenchymal transition and promotes tumorigenesis of human breast cancer cells
    Oh, Eunhye
    Kim, Ji Young
    Cho, Youngkwan
    Lee, Nahyun
    An, Hyunsook
    Kim, Jun Suk
    Seo, Jae Hong
    CANCER RESEARCH, 2015, 75
  • [43] Occurrence and significance of epithelial-mesenchymal transition in breast cancer
    Roxanis, Ioannis
    JOURNAL OF CLINICAL PATHOLOGY, 2013, 66 (06) : 517 - 521
  • [44] GATA1 induces epithelial-mesenchymal transition in breast cancer cells through PAK5 oncogenic signaling
    Li, Yang
    Ke, Qiang
    Shao, Yangguang
    Zhu, Ge
    Li, Yanshu
    Geng, Nanxi
    Jin, Feng
    Li, Feng
    ONCOTARGET, 2015, 6 (06) : 4345 - 4356
  • [45] miR-214 inhibits epithelial-mesenchymal transition of breast cancer cells via downregulation of RNF8
    Min, Lu
    Liu, Chuanyang
    Kuang, Jingyu
    Wu, Xiaomin
    Zhu, Lingyun
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2019, 51 (08) : 791 - 798
  • [46] HRG-β1-driven ErbB3 signaling induces epithelial-mesenchymal transition in breast cancer cells
    Kim, Jinkyoung
    Jeong, Hoiseon
    Lee, Youngseok
    Kim, Chungyeul
    Kim, Hankyeom
    Kim, Aeree
    BMC CANCER, 2013, 13
  • [47] Downregulation of iNOS/NO Promotes Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer
    Du, Qiang
    Liu, Silvia
    Dong, Kun
    Cui, Xiao
    Luo, Jing
    Geller, David A.
    MOLECULAR CANCER RESEARCH, 2023, 21 (02) : 102 - 114
  • [48] Epithelial-mesenchymal transition and drug resistance in breast cancer
    Huang, Jing
    Li, Hongzhong
    Ren, Guosheng
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 47 (03) : 840 - 848
  • [49] The prognostic significanc of epithelial-mesenchymal transition in breast cancer
    Fuchs, IB
    Lichtenegger, W
    Buehler, H
    Henrich, W
    Stein, H
    Kleine-Tebbe, A
    Schaller, G
    ANTICANCER RESEARCH, 2002, 22 (6A) : 3415 - 3419
  • [50] MALAT1 is crucial for epithelial-mesenchymal transition of breast cancer cells in acidic microenvironment
    Gupta, Subash C.
    Mo, Yin-Yuan
    CANCER RESEARCH, 2015, 75